TumorDiagnostik & Therapie 2016; 37(06): 337-343
DOI: 10.1055/s-0042-111306
Thieme Onkologie aktuell
© Georg Thieme Verlag KG Stuttgart · New York

Vorstellung des Screeningsystems (OncoFunction) für Funktionsstörungen im Kopf-Hals-Tumor-Follow-up

Introduction of the screening tool OncoFunction for functional follow-up of head and neck patients
V. Zebralla
1   Klinik und Poliklinik für Hals-, Nasen-, Ohrenheilkunde, Universitätsklinikum Leipzig AöR, Leipzig
,
N. Pohle
2   Hals-Nasen-Ohrenheilkunde, Universitätsklinikum Leipzig, Leipzig
,
S. Singer
3   Institute of Medical Biostatistics, Epidemiology, and Informatics, University Medical Centre Mainz, Mainz
,
T. Neumuth
4   Scientific Director, BMBF-Innovation Center Computer Assisted Surgery ICCAS, Leipzig
,
A. Dietz
5   Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde, Plastische Operationen, Universität Leipzig, Leipzig
,
M. Stier-Jarmer
6   Lehrstuhl für Public Health und Versorgungsforschung – IBE, Ludwig-Maximilians-Universität, München
,
A. Boehm
2   Hals-Nasen-Ohrenheilkunde, Universitätsklinikum Leipzig, Leipzig
› Author Affiliations
Further Information

Publication History

Publication Date:
29 August 2016 (online)

Zusammenfassung

Einleitung: Die Nachsorge von Kopf-Hals-Tumoren (KHT) fokussiert bisher auf die Therapiekontrolle. Daneben ist die Langzeitfunktionalität sehr wichtig. Diese wird beobachtet, aber nicht standardisiert erfasst. Zusätzlich bestehen bei den Patienten oft psychoonkologische Komorbiditäten, die die objektive Bewertung erschweren. Aus diesem Grunde wurde von Tschiesner et al. ein auf dem „ICF Core Set for Head and Neck Cancer“ basierender Leitfaden zur Erfassung von funktionellen Beeinträchtigungen bei Patienten mit KHT entwickelt und ein Screening-Tool vorgestellt. Mit den positiven Erfahrungen bei anderen Tumorentitäten wurde eine elektronische Version des Tools entwickelt (OncoFunction).

Methoden: In einer Machbarkeitsuntersuchung wurden alle KHT-Patienten der Klinik von 07/13 bis 03/14 eingeschlossen. OncoFunction wurde auf Tablet-PCs zum Selbstausfüllen angeboten. Die Ergebnisse standen dem Arzt zu Beginn der Konsultation zur Verfügung und wurden durch den Arztfragebogen ergänzt. Bei 202 Patienten wurde die Nutzerfreundlichkeit evaluiert.

Ergebnisse: Es fanden 682 Kontakte im Beobachtungszeitraum statt. 530 (77,7%) mal füllten die Patienten den Fragebogen aus. Zudem wurden 470 Arztchecklisten vollständig ausgefüllt. Insgesamt liegen von 68,9% der Kontakte vollständige Datensätze vor. Zwischen Teilnehmern und Nicht-Teilnehmern wurden keine Unterschiede gesehen.

Zusammenfassung: Die Nutzung eines computergestützten Screening- und Feedbacksystems (OncoFunction) im Alltag war machbar und wurde von den Patienten gut angenommen. Die Patientendaten werden sofort für den Arzt aufbereitet und rückgekoppelt, so dass für Arzt wie Patienten ein sofortiger Nutzen entsteht. Die Daten stehen für zusätzliche Anwendungen und für eine standardisierte Verlaufsdokumentation zur Verfügung.

Abstract

Introduction: The follow-up for head and neck cancer (HNC) focussed on therapy control. Accessory long term functionality is important. Impairment of function is observed, but a comparable documentation is not established. Additional we frequently see psychooncological comorbidities, what complicates the assessment. This was the reason why Tschiesner et al. developed on the base of the “ICF Core set for head and neck cancer” a guideline for the Assessment of Function in HNC. In consequence of good results in other tumour entities we developed an electronic version (OncoFunction).

Methods: In a proof of concept study all patients of our follow up consultation from 07/13 to 03/14 were included. OncoFunction was given to patients in a digital form using tablet computers. The results were visible to the physician in a concentrated form before consultation and were supplemented by a physician questionnaire. Furthermore we evaluated the usability in 202 patients.

Results: We had 682 patient contacts. 530 patient contacts (77, 7%) used the questionnaire. The physician questionnaire was answered in 470 times. Finally there are from 69.8% of the patient contacts full datasets available. Between users and non-users of the questionnaire we see no difference.

Conclusion: The use of a computer-based screening and feedback system (OncoFunction) in clinical use is feasible and excellent assessed by patients. The patient data are visible in a compact form for the physician and problems can clear addressed to the patient. One more benefit is the standardized follow up documentation and the use of comparable data in research.

 
  • Literatur

  • 1 Krebs in Deutschland 2009/2010 9 . Ausgabe. Robert Koch-Institut (Hrsg) und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. Berlin: 2013
  • 2 Fakhry C, Psyrri A, Chaturvedhi A. HPV and head and neck cancers: state-of-the-science. Oral Oncol 2014; 50: 353-355
  • 3 Pytynia KB, Dahlstrom KR, Sturgis EM. Epidemiology of HPV-associated oropharyngeal cancer. Oral Oncol 2014; 50: 380-386
  • 4 De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, Trama A, Visser O, Brenner H, Ardanaz E, Bielska-Lasota M, Engholm G, Nennecke A, Siesling S, Berrino F, Capocaccia R. and Group. EUROCARE-5 Working. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 – a population-based study. Lancet Oncol 2014; 15: 23-34
  • 5 Seiwert TY, Cohen EE. State-of-the-art management of locally advanced head and neck cancer. Br J Cancer 2005; 92: 1341-1348
  • 6 Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS, Forastiere A, Ang KK. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J ClinOncol 2008; 26: 3582-3589
  • 7 Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, Leemans CR, Aaronson NK, Slotman BJ. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J ClinOncol 2008; 26: 3770-3776
  • 8 Nguyen NP, Sallah S, Karlsson U, Antoine JE. Combined chemotherapy and radiation therapy for head and neck malignancies: quality of life issues. Cancer 2002; 94: 1131-1141
  • 9 Paleri V, Roe JW, Strojan P, Corry J, Grégoire V, Hamoir M, Eisbruch A, Mendenhall WM, Silver CE, Rinaldo A, Takes RP, Ferlito A. Strategies to reduce long-term postchemoradiation dysphagia in patients with head and neck cancer: an evidence-based review. Head Neck 2014; 36: 431-443
  • 10 Bauer F, Seiss M, Grässel E, Stelzle F, Klotz M, Rosanowski F. Swallowing-related quality of life in oral cavity cancer. The German version of the Anderson Dysphagia Inventory. HNO 2010; 58: 692-697
  • 11 List MA, Ritter-Sterr C, Lansky SB. A performance status scale for head and neck cancer patients. Cancer 1990; 66: 564-569
  • 12 Feng FY, Kim HM, Lyden TH, Haxer MJ, Worden FP, Feng M, Moyer JS, Prince ME, Carey TE, Wolf GT, Bradford CR, Chepeha DB, Eisbruch A. Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. J ClinOncol 2010; 28: 2732-2738
  • 13 Friedman M, Landsberg R, Pryor S, Syed Z, Ibrahim H, Caldarelli DD. The occurrence of sleep-disordered breathing among patients with head and neck cancer. Laryngoscope 2001; 111: 1917-1919
  • 14 Schuster M, Stelzle F. Outcome measurements after oral cancer treatment: speech and speech-related aspects – an overview. Oral Maxillofac Surg 2012; 16: 291-298
  • 15 Quinten C, Martinelli F, Coens C, Sprangers MA, Ringash J, Gotay C, Bjordal K, Greimel E, Reeve BB, Maringwa J, Ediebah DE, Zikos E, King MT, Osoba D, Taphoorn MJ, Flechtner H, Schmucker-Von Koch J, Weis J, Bottomley A. and groups, PROBE and EORTC clinical. A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites. Cancer 2014; 120: 302-311
  • 16 Fahsl S, Keszte J, Boehm A, Vogel HJ, Völkel W, Meister EF, Oeken J, Sandner A, Koscielny S, Kluge A, Heim ME, Dietz A, Singer S. Clinical relevance of quality-of-life data in laryngectomized patients. Laryngoscope 2012; 122: 1532-1538
  • 17 Singer S, Herrmann E, Welzel C, Klemm E, Heim M, Schwarz R. Comorbid mental disorders in laryngectomees. Onkologie 2005; 28: 631-636
  • 18 Singer S, Krauss O, Keszte J, Siegl G, Papsdorf K, Severi E, Hauss J, Briest S, Dietz A, Brähler E, Kortmann RD. Predictors of emotional distress in patients with head and neck cancer. Head Neck 34: 180-187
  • 19 Manikantan K, Khode S, Dwivedi RC, Palav R, Nutting CM, Rhys-Evans P, Harrington KJ, Kazi R. Making sense of post-treatment surveillance in head and neck cancer: when and what of follow-up. Cancer Treat Rev 2009; 35: 744-753
  • 20 Joshi A, Calman F, O’Connell M, Jeannon JP, Pracy P, Simo R. Current trends in the follow-up of head and neck cancer patients in the UK. ClinOncol (R CollRadiol) 2010; 22: 114-118
  • 21 AWMF. Mundhöhlenkarzinom „Diagnostik und Therapie des Mundhöhlenkarzinoms“ AWMF-Register-Nummer (007-100OL). Version 2.0 2012
  • 22 Grégoire V, Lefebvre JL, Licitra L, Felip E. and Group. EHNS-ESMO-ESTRO Guidelines Working. Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21 (Suppl. 05) v184-v186
  • 23 Rogers SN, Ahad SA, Murphy AP. A structured review and theme analysis of papers published on ‘quality of life’ in head and neck cancer: 2000-2005. Oral Oncol 2007; 43: 843-868
  • 24 Kanatas AN, Rogers SN. A systematic review of patient self-completed questionnaires suitable for oral and maxillofacial surgery. Br J Oral Maxillofac Surg 2010; 48: 579-590
  • 25 Tschiesner UM, Rogers SN, Harreus U, Berghaus A, Cieza A. Comparison of outcome measures in head and neck cancer – literature review 2000–2006. Head Neck 2009; 31: 251-259
  • 26 Roe JW, Carding PN, Dwivedi RC, Kazi RA, Rhys-Evans PH, Harrington KJ, Nutting CM. Swallowing outcomes following Intensity Modulated Radiation Therapy (IMRT) for head & neck cancer – a systematic review. Oral Oncol 2010; 46: 727-733
  • 27 Kreeft AM, van der Molen L, Hilgers FJ, Balm AJ. Speech and swallowing after surgical treatment of advanced oral and oropharyngeal carcinoma: a systematic review of the literature. EurArchOtorhinolaryngol 2009; 266: 1687-1698
  • 28 Paleri V, Thomas L, Basavaiah N, Drinnan M, Mehanna H, Jones T. Oncologic outcomes of open conservation laryngectomy for radiorecurrent laryngeal carcinoma: a systematic review and meta-analysis of English-language literature. Cancer 2011; 117: 2668-2676
  • 29 Tschiesner U, Linseisen E, Becker S, Mast G, Rogers SN, Walvekar RR, Berghaus A, Cieza A. Content validation of the international classification of functioning, disability and health core sets for head and neck cancer: a multicentre study. J. Otolaryngol Head Neck Surg 2010; 39: 674-687
  • 30 Tschiesner U, Stier-Jarmer M, Strieth S, Singer S, Dietz A, Fietkau R, Wollenberg B, Mast G, Cieza A, Harréus UA. Development of an ICF-based clinical practice guideline for the assessment of function in head and neck cancer. Laryngorhinootologie 2013; 92: 314-325
  • 31 Harréus U, Stier-Jarmer M, Tschiesner U, Cieza A, Bikowski K, Danker H, Fietkau R, Heine J, Hey C, Hofmayer A, Iro H, Kapsreiter M, Knödler M, Lüders K, Mast G, Patz M, Scheithauer H, Seitz O, Singer S et al. Leitfaden zur Erfassung von funktionellen Beeinträchtigungen bei Patienten mit Kopf-Hals-Tumoren. http://ihrs.ibe.med.uni-muenchen.de/biopsychosocial/abgeschlossen/icf_kopf_hals_tumore/download_leitfaden.pdf Sept 2013
  • 32 Stier-Jarmer M, Sabariego C, Cieza A, Harréus U, Tschiesner U. Assessment of functional outcomes in head and neck cancer. Eur Arch Otorhinolaryngol 2014; 271: 2021-2044
  • 33 Kirschneck M, Sabariego C, Singer S, Tschiesner U. Assessment of functional outcomes in patients with head and neck cancer according to the International Classification of Functioning, Disability and Health Core Sets from the perspective of the multi-professional team: results of 4 Delphi surveys. Head Neck 2014; 36: 954-968
  • 34 Buxton J, White M, Osoba D. Patients’ experiences using a computerized program with a touch-sensitive video monitor for the assessment of health-related quality of life. Qual Life Res 1998; 7: 513-519
  • 35 Chang CH. Patient-reported outcomes measurement and management with innovative methodologies and technologies. Qual Life Res 2007; 16 (Suppl. 01) 157-166
  • 36 Detmar SB, Muller MJ, Schornagel JH, Wever LD, Aaronson NK. Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA 2002; 288: 3027-3034
  • 37 Wright EP, Selby PJ, Crawford M, Gillibrand A, Johnston C, Perren TJ, Rush R, Smith A, Velikova G, Watson K, Gould A, Cull A. Feasibility and compliance of automated measurement of quality of life in oncology practice. J ClinOncol 21: 374-382
  • 38 International Society for Quality of Life Research . prepared by Aaronson N, Choucair A, Elliott T, Greenhalgh J, Halyard M, Hess R, Miller D, Reeve B, Santana M, Snyder C. User’s Guide to Implementing Patient-Reported Outcomes Assessment in Clinical Practice. Version: November 11, 2011
  • 39 Holzner B, Schauer-Maurer G, Stockhammer G, Muigg A, Hutterer M, Giesinger J. Patient reported outcome monitoring using a tablet PC is suitable for measuring quality of life in patients with gliomas. Wien MedWochenschr 2011; 161: 6-12
  • 40 Klinkhammer-Schalke M, Koller M, Steinger B, Ehret C, Ernst B, Wyatt JC, Hofstädter F, Lorenz W. and Group, Regensburg QoL Study. Direct improvement of quality of life using a tailored quality of life diagnosis and therapy pathway: randomised trial in 200 women with breast cancer. Br J Cancer 2012; 106: 826-838
  • 41 Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J ClinOncol 1982; 5: 649-655
  • 42 Anscher MS, Gold DT. Literacy and laryngectomy: how should one treat head and neck cancer in patients who cannot read or write?. South Med J 1991; 84: 209-213
  • 43 Koay K, Schofield P, Gough K, Buchbinder R, Rischin D, Ball D, Corry J, Osborne RH, Jefford M. Suboptimal health literacy in patients with lung cancer or head and neck cancer. Support Care Cancer 2013; 8: 2237-2245